Find Academic Supervisors

Nikolaos LourosView profile

Assistant Professor

• Protein Misfolding and Aggregation
• Amyloid Formation
• Neurodegenerative Diseases
• +7 more

Nikolaos Louros is an Assistant Professor at UT Southwestern Medical Center, with dual affiliations to the Center for Alzheimer's and Neurodegenerative Diseases (CAND) and the Department of Biophysics. He leads the Louros Lab, which focuses on protein misfolding, aggregation, and amyloid formation in neurodegenerative diseases. His research integrates AI-driven protein engineering with biophysical, structural, and cellular methods to develop novel therapeutics. B.S. in Biology, National and Kapodistrian University of Athens (2011) MSc in Bioinformatics (2014) Ph.D. in Cell Biology and Biophysics, NKUA (2016) Postdoctoral training at VIB-KU Leuven Center for Brain & Disease Research, Belgium Dr. Louros' research centers on the molecular mechanisms of protein aggregation, particularly in Alzheimer’s and Parkinson’s diseases. His lab investigates amyloid polymorphism, heterotypic interactions, and the role of post-translational modifications like glycosylation in proteostasis. Using computational tools and experimental validation, his team aims to identify aggregation modifiers and design novel inhibitors. His recent publications reveal a strong focus on amyloid structure, calcium dysregulation, and therapeutic targeting. Key themes include tau and Aβ polymorphism, co-aggregation with proteins like Medin, and the use of AI to map aggregation-prone sequences. His work frequently appears in top-tier journals such as Nature , Science , Cell , and Nature Reviews Molecular Cell Biology . Pharmacological modulation of septins in Alzheimer’s models Medin-Aβ co-aggregation in vascular amyloid AI-guided mapping of amyloid sequence space Structural basis of tau polymorphism Therapeutic targeting of pathogenic tau seeds Dr. Louros has not been listed with formal scientific awards in the provided text, but his publication record and leadership role indicate significant recognition. He is actively mentoring students and postdocs, as his lab is recruiting for Ph.D. candidates and research associates. The Louros Lab operates within the Peter O'Donnell Jr. Brain Institute, fostering interdisciplinary collaboration in neuroscience and biophysics. The lab employs a hybrid, inquiry-driven approach, combining deep learning, protein engineering, and high-throughput experimentation. It maintains strong collaborative ties with leading institutions and researchers in the field of neurodegeneration and protein science.

Jennifer De Los SantosView profile

Professor

• Breast Cancer
• Radiation Therapy
• Head and Neck Cancers
• +5 more

Jennifer De Los Santos, MD is a Professor of Radiation Oncology at Washington University School of Medicine in St. Louis. She serves in the Department of Radiation Oncology and is part of the Siteman Cancer Center. Dr. De Los Santos is a nationally recognized expert in breast cancer although her current clinical and research focus centers on cancers of the head and neck. She has held leadership positions including Chairman of Radiation Oncology and Cancer Center Director at Grandview Cancer Center in Birmingham, Alabama, and has led national studies in breast cancer through the TBCRC and NRG oncology groups. Dr. De Los Santos' educational background includes a BS in Psychology from Emory University (1991), an MD from the University of Florida (1995), and completed her residency in Radiation Oncology at MD Anderson Cancer Center (2001). Her research interests span breast cancer treatment, radiation therapy techniques, and head and neck cancers, with particular focus on developing paradigm-shifting treatment approaches and translational work to define populations who may successfully proceed with these approaches. Her publication record demonstrates consistent productivity with 68 research outputs and 2973 citations. Recent work shows a strong focus on breast cancer staging systems, pathological response prediction, and innovative treatment approaches including novel combinations of targeted therapies with radiation. Her research often involves large national clinical trials through NRG Oncology and other cooperative groups. Dr. De Los Santos has served in leadership roles at the Translational Breast Cancer Research Consortium (TBCRC), the University of Alabama at Birmingham, and has been involved in numerous national clinical trials that have shaped breast cancer treatment guidelines. Her work bridges clinical practice and research, with emphasis on improving outcomes for cancer patients through innovative treatment approaches and better understanding of treatment response predictors.

Al-Hafeez Z DhallaView profile

Assistant Professor

• Biomedical Optics
• Optical Coherence Tomography
• Scanning Laser Ophthalmoscopy
• +6 more

Al-Hafeez Z Dhalla serves as an Assistant Research Professor in the Department of Biomedical Engineering at Duke University and is a Faculty Network Member of the Duke Institute for Brain Sciences. His academic appointment reflects his engineering expertise in translating optical technologies to clinical ophthalmology applications. He earned his Ph.D. from Duke University in 2012, establishing a foundation for his specialized work in biomedical optics. This educational trajectory directly informs his current research and teaching activities within the university's engineering framework. Dr. Dhalla's research program centers on developing optical coherence tomography (OCT), scanning laser ophthalmoscopy (SLO), and LiDAR systems for non-invasive, high-resolution biological tissue imaging. His laboratory specifically targets ophthalmic disease diagnosis and treatment, with strong emphasis on engineering novel instrumentation for image-guided surgery and robotic microsurgery. A critical aspect of his work involves preparing these technologies for commercialization through rigorous clinical validation and regulatory approval processes, bridging the gap between engineering innovation and medical practice. His publication portfolio demonstrates consistent advancement in optical imaging technologies, particularly handheld OCT devices, real-time volumetric surgical imaging, and adaptive optics for photoreceptor visualization. The research exhibits a clear trajectory from fundamental optical engineering toward clinical implementation, with recurring themes of enhancing surgical precision through robotic integration and improving diagnostic capabilities via novel scanning methodologies. Within the educational sphere, Dr. Dhalla teaches multiple courses including BME 791 (Graduate Independent Study), BME 590 (Special Topics), BME 494/493 (Projects in Biomedical Engineering), and BME 436L (Biophotonic Instrumentation), directly connecting his research expertise to student training in optical instrumentation and biomedical device development.

Mark C. FishmanView profile

Professor

• Cardiovascular Development
• Neurobiology
• Zebrafish Genetics
• +4 more

Mark C. Fishman, M.D., is a Professor of Stem Cell and Regenerative Biology at Harvard University and affiliated with the Harvard Stem Cell Institute. His laboratory investigates the heart-brain axis using zebrafish to map autonomic control circuits and decode the genetic/neuronal basis of vertebrate social behavior . From 2002-2016, he led Novartis Institutes for Biomedical Research, advancing 90 medicines to clinical trials, with a focus on regenerative therapies for aging disorders. Education : Yale College (A.B.), Harvard Medical School (M.D.) Academic Leadership : Former Chief of Cardiology and Director of Cardiovascular Research Center at Harvard Medical School and MGH Research spans cardiovascular development , neurogenetics , and translational medicine , with seminal work on zebrafish genetic screens in the 1990s establishing pathways for vertebrate organ formation. His lab introduced zebrafish as a model for dissecting social interaction circuits and homeostatic regulation . Current work explores how internal sensory systems shape behavior through genetic and pharmacological interventions. Recent publications highlight zebrafish studies on age-related vascular calcification (αKlotho), dopamine transporter mutations (psychiatric models), and collective behavior genetics . Articles span 1996-2025, reflecting continuous contributions to Developmental Biology , Neuroscience , and Cardiovascular Research . Awards include election to the National Academy of Medicine (20-year member), Fellow of the American Academy of Arts and Sciences , and leadership roles in biotech (Aditum Bio, Beam Therapeutics). He authored the textbook Medicine and Lab: Building a Home for Scientists , bridging architectural design with scientific innovation. Teaching includes SCRB 197/297 Frontiers in Therapeutics , examining disease elimination promises and personalized medicine through historical and modern therapeutic frameworks. His lab in Sherman Fairchild Building (Cambridge, MA) continues mentoring interdisciplinary researchers in cardiovascular-neurobiological interfaces.

• Cognitive Neuroscience
• Neuroimaging
• Autism Spectrum Disorders
• +4 more

Susan Y. Bookheimer, PhD, is Professor-in-residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles. From 2008 to 2024 she held the endowed Joaquin M. Fuster Chair in Cognitive Neuroscience and currently directs or co-directs several large-scale NIH consortia including the UCLA site of the Adolescent Brain Cognitive Development (ABCD) Study, the Lifespan Human Connectome Project in Aging, and newly funded initiatives on resilience to Alzheimer’s disease in centenarians. Education & Training Details of formal degrees are not provided in the source text; however, her continuous NIH funding since 1995 and leadership roles imply advanced research training in clinical neuroscience and neuroimaging. Research Focus Dr. Bookheimer’s work integrates multimodal neuroimaging (fMRI, sMRI, DTI, PET, EEG) with genetics, cognitive testing, and clinical phenotyping to understand: Typical and atypical brain development across the lifespan Neurobiological underpinnings of autism spectrum disorder and sensory phenotypes Early detection and prediction of Alzheimer’s disease and age-related cognitive decline Neuroplasticity and cognitive outcomes following epilepsy surgery Effects of environmental adversity, stress, and social support on brain networks Scientific Awards & Honors Joaquin M. Fuster Chair in Cognitive Neuroscience, UCLA (2008–2024) Principal or Co-Principal Investigator on >15 active NIH grants totaling >$100 M Over 230 peer-reviewed publications with >25,000 citations (Google Scholar metrics) Grants & Consortia Leadership Dr. Bookheimer currently leads or co-leads the following major NIH projects: U19AG073585 – Vulnerability and Resiliency in the Aging Adult Brain Connectome (AABC) U19AG073172 – Resilience/Resistance to Alzheimer’s Disease in Centenarians and Offspring (RADCO) R01AG073480 – Modulation of Hippocampal Circuitry with Focused Ultrasound in Amnestic MCI P50HD103557 – UCLA Intellectual and Developmental Disabilities Research Center U01DA050987 – ABCD-USA Consortium Research Project Site at UCLA U01AG052564 – Mapping the Human Connectome During Typical Aging U01MH109589 – Mapping the Human Connectome During Typical Development In addition, she has served as PI on prior awards including P50HD055784 (Autism Center), R01AG013308 (Alzheimer’s Risk), and P30HD004612 (IDDRC). Laboratories & Teams Dr. Bookheimer directs the UCLA Brain Mapping Center (part of the Ahmanson-Lovelace Brain Mapping Center) and co-directs imaging cores for both the UCLA IDDRC and the ABCD Study. Her multidisciplinary teams include post-doctoral fellows, graduate students, research staff, and collaborators across neurology, radiology, psychology, and genetics departments.

• Neuroscience
• Astrocyte Biology
• Calcium Signaling
• +5 more

Dr. Baljit S. Khakh is a Professor of Neurobiology and Physiology at the David Geffen School of Medicine, University of California, Los Angeles. He holds the Eleanor I. Leslie Chair of Neuroscience and leads groundbreaking research on astrocyte biology, calcium signaling, and their roles in neural circuits and neurodegenerative diseases. His work integrates optical/genetic tools with proteomic and behavioral studies, funded by multiple NIH grants including R01, R35, and DP1 awards. Research Focus: Astrocyte diversity, calcium signaling, Huntington's disease, Alzheimer's pathology, neural circuit modulation. Key Collaborations: Michael Sofroniew (UCLA), Loren Looger (Janelia), James Wohlschlegel (UCLA), Peyman Golshani (UCLA). Techniques: Genetically-encoded sensors, proximity biotinylation, in vivo calcium imaging, astrocyte-neuron interaction assays. Scientific Awards: Eleanor I. Leslie Chair of Neuroscience

• Computational Neuroscience
• Cognitive Decision Making
• Social Neuroscience
• +3 more

Wako Yoshida is Professor of Clinical Neuroscience at the University of Oxford's Nuffield Department of Clinical Neuroscience, leading research at the intersection of computational neuroscience, decision theory, and social cognition. Her work focuses on neural mechanisms of belief construction during partially observable decision-making and social interactions, with particular emphasis on prefrontal cortex function. Her research interests include: Computational modeling of uncertainty resolution in cognitive decision-making Neural basis of Theory of Mind during cooperative social interactions Pain neuroscience and aversive learning mechanisms Application of hyper-scanning fMRI for group decision-making studies Brain-machine interfaces for pain control through co-adaptive learning Analysis of her 15 most recent publications (2016-2024) reveals three dominant trends: (1) Neural mechanisms of hierarchical belief inference in spatial navigation and social contexts, (2) Uncertainty processing in pain modulation involving prefrontal-periaqueductal circuits, and (3) Development of computational frameworks for brain-machine interfaces targeting chronic pain management. Her work consistently bridges machine learning concepts with human neuroimaging. Scientific awards: No awards mentioned in source material. Advising and grants: Source text provides no details about students, advisees, or grant funding. Yoshida directs the Pain and Aversive Learning research group at Oxford, collaborating with Ben Seymour and others to investigate computational and neural mechanisms underlying pain, aversion, and decision-making using fMRI, hyper-scanning, and computational modeling approaches.

Miriam B. GoodmanView profile

Professor

• Neuroscience
• Molecular Biology
• Mechanotransduction
• +5 more

Miriam B. Goodman holds the Mrs. George A. Winzer Professorship of Cell Biology at Stanford University , with affiliations in the Department of Molecular and Cellular Physiology , Bio-X , and the Wu Tsai Neurosciences Institute . As Chair of the Molecular and Cellular Physiology Department (2017–present) and former Deputy Director of the Stanford Neuroscience Institute (2013–2017), she leads interdisciplinary research bridging neuroscience, biophysics, and molecular physiology . Education : Ph.D. in Neurobiology, The University of Chicago (1995) Sc.B. in Biochemistry, Brown University (1986) Her research focuses on molecular mechanotransduction using C. elegans to investigate touch sensation, temperature detection, and neuronal stress resilience . Key methodologies include quantitative behavioral analysis , CRISPR gene editing , and in vivo electrophysiology . Recent work explores mechanical forces in feeding through upconverting microgauges and chemosensory integration of plant-derived molecules. Her publications span neurobiological mechanisms , biomechanical sensor design , and ecological signal processing , with a 2025 Nature study on ingestible nanosensors and a 2024 Current Biology paper on mechanosensory complex organization . Scientific Awards : Distinguished Alumni Award, University of Chicago (2024) Landis Award for Outstanding Mentoring, NIH (2019) Michael and Kate Barany Award, Biophysical Society (2014) Klingenstein Fellow in Neuroscience (2005-2008) McKnight Scholar Award (2005-2008) Prize in Neurobiology, Eppendorf & Science (2004) As an advisor, she mentors doctoral candidates in the Biophysics , Molecular and Cellular Physiology , and Neurosciences Ph.D. programs , including Madeline Cooper and Caroline Arellano-Garcia. Her lab collaborates with UC San Diego's Vergassola Group on mechanosensory physics and Stanford Microsystems Lab on optical sensor design .

Charles BurantView profile

Professor

• Obesity
• Type 2 Diabetes
• Insulin Resistance
• +5 more

Charles Burant is Professor of Nutritional Sciences at the University of Michigan School of Public Health and holds a professorship in the Section of Metabolism, Endocrinology, and Diabetes within the Medical School's Department of Internal Medicine. He holds the endowed Dr. Robert C. and Veronica Atkins Professor of Metabolism chair. His clinical practice focuses on obesity, type 2 diabetes, and related metabolic disorders at the WK Kellogg Eye Center, Brehm Tower in Ann Arbor. Dr. Burant's research integrates multi-omic approaches (genomics, transcriptomics, proteomics, metabolomics) with clinical and behavioral phenotypes to unravel mechanisms of obesity, insulin resistance, and diabetes. His laboratory investigates pancreatic beta-cell metabolism, insulin secretion dynamics, and adult pancreatic progenitor cells for beta-cell regeneration. As director of the Michigan Metabolomics and Obesity Center (MMOC), he oversees the NIH-funded Nutrition Obesity Research Center and Michigan Regional Comprehensive Metabolomics Resource Core, providing critical infrastructure for metabolic disease research. The MMOC also coordinates the Investigational Weight Management Clinic, which combines clinical care with phenotypic tracking to study diabetes prevention and weight regain mechanisms in formerly obese patients. Analysis of his recent publications reveals dominant themes in multi-omic exercise physiology, causal metabolite-disease relationships, and tissue-specific metabolic adaptations. His work consistently emphasizes sexual dimorphism, temporal dynamics, and molecular mechanisms in metabolic disorders, particularly through large-scale consortia like MoTrPAC. Key focus areas include lipid metabolism in disease contexts, adipose tissue remodeling, and mitochondrial function across tissues. While no specific scientific awards beyond his endowed chair are listed, his leadership of major NIH-funded centers demonstrates significant recognition. His grant portfolio includes infrastructure support through the MMOC, NORC, and Metabolomics Resource Core, enabling extensive human and animal studies in metabolic diseases. Dr. Burant directs the MMOC's integration of research and clinical care through the Investigational Weight Management Clinic. His laboratory maintains active programs in insulin resistance mechanisms using animal models and explores pancreatic progenitor cell applications for diabetes therapy, representing forward-looking approaches to metabolic disease treatment.

Vanni BucciView profile

Professor

• Host-microbiome interactions
• Computational biology
• Synthetic biology
• +5 more

Professor Vanni Bucci is a faculty member at the UMass Chan Medical School in the Department of Microbiology, with an adjunct appointment at the University of Massachusetts Dartmouth. His research focuses on host-microbiome interactions through computational biology, synthetic biology, and systems biology approaches. He received education at the University of Florence (BS Environmental Engineering) and Northeastern University (MS/PhD Civil Engineering), followed by postdoctoral work at Memorial Sloan-Kettering Cancer Center. Current research spans microbiome engineering , immune modulation , and antimicrobial discovery , with recent publications on microcins, gut-brain axis dynamics, and tuberculosis microbiome interactions. Host-microbiome interactions Synthetic biology applications Computational modeling of microbiomes Antimicrobial peptide engineering His lab develops bioinformatic tools like MDITRE for microbiome prediction, while recent articles demonstrate expertise in Clostridioides difficile colonization resistance, Enterobacteriaceae inhibition, and Alzheimer's disease microbiome connections. Collaborations span institutions including Weill Cornell, NIH, and Gates Foundation. Scientific Awards & Funding NIH U01 grant ($2.9M) for intestinal barrier-targeted therapeutics Bill & Melinda Gates Foundation grant for microbiome intervention methods Department of Defense funding for ESBL-PE eradication

Isaac KauvarView profile

Research Fellow

• Neuroscience
• Photonics
• Neurotechnology
• +3 more

Isaac Kauvar is a Postdoctoral Fellow at the Department of Electrical Engineering, School of Engineering, Stanford University. He holds a B.S. in Engineering Physics specializing in Photonics, an M.S. in Electrical Engineering focusing on Imaging and Optimization, and is currently pursuing a PhD in Electrical Engineering under the co-advisement of Prof. Gordon Wetzstein. Education B.S. Engineering Physics, Stanford M.S. Electrical Engineering, Stanford His research bridges Neuroscience, Photonics, and Computational Modeling to develop advanced imaging and neural activity measurement technologies. Key contributions include optical brain-computer interfaces, light-field microscopy innovations, and neural circuit analysis across species. Recent publications highlight work in cortical imaging, emotional response modeling, and neurotechnology development. His expertise spans optical systems design, neural dynamics analysis, and brain state modulation. Contact: ikauvar@stanford.edu

Michelle Mazei-RobisonView profile

Professor

• Neuroscience
• Psychiatric Disorders
• Addiction Research
• +7 more

Michelle Mazei-Robison is a Professor in the Department of Physiology at Michigan State University and faculty member in the Neuroscience Program, with an additional appointment as Associate Professor in the BioMolecular Science Gateway. Her research laboratory, located at 5017 766 Service Road, Room 5017, focuses on molecular mechanisms underlying psychiatric disorders including depression and addiction, utilizing the chronic social defeat mouse model to investigate the mesocorticolimbic dopamine system. Her primary research interests center on neuroadaptations in ventral tegmental area (VTA) dopamine neurons induced by stress and drugs of abuse. She investigates structural and functional changes in VTA neurons, signaling pathways altered by morphine/cocaine exposure, and subtype-specific responses within dopaminergic circuits. Her lab employs cutting-edge methodologies including optogenetics, viral-mediated gene transfer, 3D neuronal reconstruction, and behavioral assays to unravel mechanisms of depression and addiction. Analysis of her 2020-2025 publications reveals consistent focus on VTA neuronal subpopulations (particularly neuromedin S and GLP-1 expressing neurons), SGK1 kinase signaling in drug reward, and sex-specific stress responses. Her work demonstrates how molecular adaptations in dopamine neurons mediate morphine/cocaine behaviors while exploring hippocampal contributions to stress resilience through ΔFosB regulation. Scientific Awards: No awards were documented in the provided sources. Advising and Grants: The available materials list no specific students, grant awards, or mentoring activities. Her laboratory operations and publication record indicate active research funding, though exact mechanisms remain unspecified in the source texts. Labs and Teams: Dr. Mazei-Robison co-directs the Robison and Mazei-Robison Labs, which integrate mouse models, genetic engineering, electrophysiology, and advanced microscopy to study comorbid conditions like opiate abuse with PTSD. The lab bridges molecular mechanisms (gene expression, protein function) across multiple neural systems to explain behavioral outcomes in addiction and depression.

Adina T Michael-TitusView profile

Professor

• Neuroscience
• Pharmacology
• Neuroprotection
• +5 more

Adina T Michael-Titus is a Professor of Neuroscience at Queen Mary University of London, affiliated with the Blizard Institute under the Faculty of Medicine and Dentistry. She leads the Neurotrauma Group in the Centre for Neuroscience, Surgery and Trauma, focusing on neuroprotective and neurorepair strategies for neurological diseases. Doctorat en Sciences (France) in 1988 Lic Sci, M es Sci, Doct en Sci (Paris) Her research spans neuroprotection , spinal cord injury , traumatic brain injury , and neurodegeneration , with a focus on natural compounds like n-3 polyunsaturated fatty acids. She has developed fatty acid emulsions and specialized medical nutrients for acute neuroprotection, targeting white matter aging and biomarker discovery. Key trends in her publications include neuroprotective agents , nutritional interventions , and neuroplasticity in injury models, with translational applications in clinical settings. Her work has resulted in multiple patents and collaborations with pharmaceutical companies like Lundbeck A/S. Scientific Awards Fellow of the British Pharmacological Society Fellow of The Higher Education Academy Board of Directors, International Society for Studies on Fatty Acids and Lipids As Programme Director for the MSc in Neuroscience and Translational Medicine , she supervises PhD students including Lucas Baumard, Rachel Ingram, Zahra Falah, Hassan Al-Khateeb, and Eleanor Sams. Her teaching includes modules in neuroscience, pharmacology, and neuropharmacology at both undergraduate and postgraduate levels. Her research is supported by grants from the UK research councils, and she regularly acts as a reviewer for these bodies. The Neurotrauma Group she leads investigates therapeutic strategies for brain and spinal cord injuries, emphasizing rapid clinical translation of fundamental discoveries.

• Stroke and Cerebrovascular Diseases
• Stroke Epidemiology
• Acute Stroke Treatment
• +5 more

Agnethe Eltoft serves as an Associate Professor at the Department of Clinical Medicine, UiT The Arctic University of Norway, and concurrently holds the position of senior consultant at the Neurology Section of the University Hospital of Northern Norway. She is an active member of the Brain and Circulation Research Group, contributing significantly to stroke research and clinical practice in northern Norway. Her primary research interests focus on stroke and cerebrovascular diseases, with specialization in stroke epidemiology, acute stroke treatment protocols, biomarker discovery, and neuroimaging applications in stroke management. Her work extends to carotid atherosclerosis, pre-hospital thrombolysis, and the emerging field of artificial intelligence applications in stroke care. This multidisciplinary approach bridges clinical practice with population-based research, particularly through the Tromsø Study and the Norwegian Stroke Registry. Analysis of her recent publications reveals a strong emphasis on wake-up stroke management, thrombolytic therapy optimization, and the implementation of evidence-based stroke treatments across Norway. Her work demonstrates consistent contributions to large-scale clinical trials like TWIST and NOR-TEST 2, with increasing focus on AI applications in stroke diagnosis and treatment. As an educator, Dr. Eltoft teaches clinical neurology and contributes to professional and scientific communication modules ("profkom" and "vitkom") in medical education. She serves as a supervisor for master's and PhD students, mentoring the next generation of neurologists and stroke researchers. Her research projects include Acute Stroke Treatment - TWIST, Carotid Atherosclerosis studies, Pre-hospital Thrombolysis initiatives, AI in Stroke Care development, and comprehensive Stroke Epidemiology investigations. Dr. Eltoft maintains an active clinical presence while contributing to healthcare improvement through publications addressing systemic challenges in stroke care, such as geographical disparities in treatment access and post-stroke monitoring protocols. Her work with the Norwegian Stroke Registry provides critical data for national stroke care quality improvement initiatives.

Mitchell SutterView profile

Professor

• Neuroscience
• Auditory Perception
• Sensory Systems
• +5 more

Mitchell Sutter is a Professor at the University of California, Davis , affiliated with the Department of Neurobiology, Physiology and Behavior and the Center for Neuroscience . His research explores auditory perception, neural coding of sound, and the role of higher brain areas in decision-making and attention during complex auditory environments. Combines neuroscience , behavior , and quantitative methods to study auditory systems. Focus on auditory cortex and its role in sound-guided behavior . Investigates attentional modulation of neural activity. Recent work emphasizes temporal modulation , amplitude modulation , and perceptual restoration in auditory processing. Publications span neurophysiological analysis , cross-species studies , and behavioral neuroscience .